基本医疗保障制度下完善我国罕见病高价值治疗药物医保准入的思路探讨
朱琳, 胡嘉浩, 刘宇晗, 李芬, 金春林
Discussion on improving the medical insurance access of high-value orphan drugs in
China under the basic medical insurance system
ZHU Lin, HU Jiahao, LIU Yuhan, LI Fen, JIN Chunlin
世界临床药物
.
2023, (09): 994
-1000
.
DOI: 10.13683/j.wph.2023.09.017
